ライフサイエンスコーパス: needle aspiration

1 gnostic confirmation when combined with fine needle aspiration.

2 ompression source were performed before fine-needle aspiration.

3 h node status defined by ultrasound and fine needle aspiration.

4 ed in resolution and ability to perform fine needle aspiration.

5 arations obtained by minimally invasive fine needle aspiration.

6 ogic evaluations, and early performance fine-needle aspiration.

7 than in tissue removed surgically or by fine-needle aspiration.

8 etrics between TTMV-HPV DNA testing and fine-needle aspiration.

9 d samples obtained by ultrasound-guided fine-needle aspiration.

10 rms from screening or ultrasound-guided fine-needle aspiration.

11 anoma cells was evaluated in vitro following needle aspiration.

12 er reactions, as assessed by lymph node fine needle aspiration.

13 is currently done on tumor biopsies or fine-needle aspirations.

14 needle biopsy (50% [17/34] P = .04) and fine needle aspiration (0% [0/2]; P = .009).

15 cured with endoscopic ultrasound-guided fine-needle aspiration 1 week before and 2 weeks after chemo-

16 centric breast lesions proven by either fine-needle aspiration (19/59), core biopsy (39/59), or lumpe

17 ion in patients with negative transbronchial needle aspiration; (4) sensitivity, specificity, and dia

18 d set 2-95 endoscopic ultrasound-guided fine-needle aspirations (60 PDAC, 9 IPMN, 26 C).

19 93%), and ultrasound guided parathyroid fine needle aspiration (78%).

20 170 patients who underwent preoperative fine-needle aspiration (91.8%), a benign tumor was diagnosed;

21 In the present study, we used fine-needle aspiration (a nonterminal sampling method) to col

22 ombination of endoscopic ultrasound and fine-needle aspiration analysis for KIT expression may be use

23 that are cytologically indeterminate on fine-needle aspiration and benign according to gene-expressio

24 Fine-needle aspiration and biopsy of bone led to reduced abil

25 In patients undergoing both fine-needle aspiration and biopsy, the former proved diagnost

26 ected to be an infected parasitic cyst; fine-needle aspiration and cytology were not attempted due to

27 tical obstacles of liver sampling using fine-needle aspiration and develop an optimized workflow to c

28 Both fine-needle aspiration and intraoperative frozen section anal

29 and yield methodology, (4) incorporation of needle aspiration and other newer techniques, and (5) co

30 invasive techniques such as testicular fine-needle aspiration and percutaneous needle biopsy are fea

31 may provide a tissue diagnosis through fine-needle aspiration and staging through ultrasound imaging

32 of ductal carcinoma-in-situ, the use of fine-needle aspiration and stereotactic biopsy for diagnosis,

33 eld, we prospectively studied transbronchial needle aspiration and the sequential effect of each succ

34 clinical samples, including cells from fine needle aspiration and tissues obtained via core needle b

35 can improve the diagnostic accuracy of fine-needle aspirations and provide prognostic information.

36 rative studies such as ultrasonography, fine-needle aspiration, and better molecular and genetic mark

37 ge analysis, endoscopic ultrasound with fine needle aspiration, and cholangioscopy.

38 ecessary workup in the form of imaging, fine-needle aspiration, and diagnostic surgery.

39 gone surgical drainage, 10 who had undergone needle aspiration, and one who had undergone surgical de

40 scopy and endoscopic ultrasound-guided, fine-needle aspiration are key components in the diagnosis of

41 f thyroid nodules evaluated by means of fine-needle aspiration are not clearly benign or malignant.

42 ired by endoscopic ultrasound transbronchial needle aspiration are sufficient for molecular testing i

43 Pancreatic fine-needle aspirations are the gold-standard diagnostic proc

44 dobronchial ultrasound-guided transbronchial needle aspiration as an initial investigation technique

45 iopsies, and endoscopic ultrasound with fine-needle aspiration at regular intervals.

46 Herein, through a fine-needle aspiration-based approach, we profiled the immune

47 problems such as the suspicious thyroid fine needle aspiration, better treatment algorithms for well

48 ogy now allow the detection of these in fine needle aspiration biopsies (FNA).

49 logical evaluation can be acquired with fine-needle aspiration biopsies (FNAB) controlled with CT and

50 on data (gene chips) was generated from fine-needle aspiration biopsies (n = 229) prospectively colle

51 ons of human Tg from needle washouts of fine-needle aspiration biopsies of thyroid nodule from differ

52 ms to standardise assessment and reduce fine-needle aspiration biopsies through risk stratification.

53 A total of 209 fine-needle aspiration biopsies were performed on 156 patient

54 atients, paired diagnostic transscleral fine needle aspiration biopsies were performed using both 25

55 ors were conducted and compared with 86 fine-needle aspiration biopsies(FNAB) of lung and mediastinum

56 mits its access to isolated rare cells, fine needle aspiration biopsies, and tissue substructures.

57 tection of Tg in the needle washouts of fine-needle aspiration biopsies, at concentrations useful for

58 r histologically proved after US-guided fine-needle aspiration biopsy (eight lesions) or core biopsy

59 Endosonography-guided fine-needle aspiration biopsy (EUS-FNA) permits cytological c

60 Serum, liver fine needle aspiration biopsy (FNA), and liver core needle bi

61 h posterior uveal melanoma evaluated by fine-needle aspiration biopsy (FNAB) at the time of or shortl

62 Fine-needle aspiration biopsy (FNAB) for DNA amplification an

63 In Lusaka, Zambia, we introduced liver fine-needle aspiration biopsy (FNAB) into a research cohort o

64 Fine-needle aspiration biopsy (FNAB) of tumor for DNA amplifi

65 potentially devastating complication of fine-needle aspiration biopsy (FNAB) or open biopsy is extrao

66 The majority of nodules with fine needle aspiration biopsy (FNAB) results that are classif

67 erform the first in vivo examination of fine needle aspiration biopsy (FNAB) scleral tracts to determ

68 ity of BRAF mutation testing of thyroid fine-needle aspiration biopsy (FNAB) specimens for preoperati

69 CGA classification to UM biopsied using fine-needle aspiration biopsy (FNAB) to determine the predict

70 July 2013 who underwent prognostication fine-needle aspiration biopsy (FNAB) were included.

71 th ultrasonography (US) and US-assisted fine needle aspiration biopsy (FNAB).

72 < 0.01) and those involved with thyroid fine-needle aspiration biopsy (p < 0.01).

73 ved linear-array instruments, real-time fine-needle aspiration biopsy (RTFNA) of pancreatic lesions c

74 as well as sex, source of tumor tissue (fine-needle aspiration biopsy [FNAB] compared with tumor from

75 Fine-needle aspiration biopsy also allows characterization of

76 yroid nodules; and peripheral blood and fine-needle aspiration biopsy analysis of molecular markers,

77 gnosis was made using ultrasound-guided fine needle aspiration biopsy and consequent cytopathological

78 Fine-needle aspiration biopsy and core biopsy are important p

79 d to improve the diagnostic accuracy of fine needle aspiration biopsy and cytologic examination.

80 riod who were evaluated with prognostic fine-needle aspiration biopsy at the time of primary treatmen

81 uveal melanoma who underwent prognostic fine-needle aspiration biopsy at the time of primary treatmen

82 Percutaneous fine-needle aspiration biopsy can be used for the diagnosis o

83 Fine-needle aspiration biopsy confirmed the diagnoses (n = 4)

84 Clear corneal fine-needle aspiration biopsy confirmed the diagnosis as reti

85 ly, some population-based studies using fine-needle aspiration biopsy data report no linkage between

86 demiology, Initial Evaluation, Imaging, Fine Needle Aspiration Biopsy Diagnosis, Molecular Testing, I

87 demiology, Initial Evaluation, Imaging, Fine Needle Aspiration Biopsy Diagnosis, Molecular Testing, I

88 The preferred approach when repeated fine-needle aspiration biopsy fails to yield an adequate spec

89 chytherapy and underwent intraoperative fine-needle aspiration biopsy for cytopathology and uveal mel

90 Fine-needle aspiration biopsy for metastatic prognostication

91 Fine-needle aspiration biopsy for prognostication in choroida

92 Mutation analysis in thyroid nodule fine needle aspiration biopsy has been applied to improve the

93 Core-needle biopsy in comparison to fine-needle aspiration biopsy has more frequent rate of negli

94 Fine-needle aspiration biopsy has resulted in substantial imp

95 Fine-needle aspiration biopsy identifies the childhood thyroi

96 vitrectomy and 25-gauge trans-vitrector port needle aspiration biopsy immediately before brachytherap

97 kers that could improve the accuracy of fine needle aspiration biopsy in the evaluation of patients w

98 ne patient and a percutaneous CT-guided fine needle aspiration biopsy in the other disclosed normal t

99 US-guided fine-needle aspiration biopsy is a simple, rapid, inexpensive

100 Fine-needle aspiration biopsy is an alternative to open biops

101 Fine-needle aspiration biopsy is both accurate and cost-effec

102 Fine-needle aspiration biopsy is more reliable in distinguish

103 Fine-needle aspiration biopsy is not perfect and adjuncts whi

104 Tissue sampling with fine-needle aspiration biopsy is recommended.

105 Fine-needle aspiration biopsy is the standard diagnostic test

106 Fine-needle aspiration biopsy MT for BRAF, RAS, PAX8-PPARgamm

107 e were originated simultaneously from a fine needle aspiration biopsy of a metastasis in a patient wi

108 "highly suggestive of malignancy." For fine-needle aspiration biopsy of a palpable lump performed by

109 The diagnosis was made by fine-needle aspiration biopsy of a pulmonary nodule.

110 Fine-needle aspiration biopsy of choroidal melanoma offers an

111 12 to December 2014 from intraoperative fine-needle aspiration biopsy of choroidal tumors undergoing

112 Fine-needle aspiration biopsy of large thyroid nodules has a

113 ve lower respiratory tract samples; and fine needle aspiration biopsy of lymph nodes.

114 rasonography and ultrasonography-guided fine-needle aspiration biopsy of nodules at least 1 cm in max

115 s and as a guidance system for directed fine-needle aspiration biopsy of suspicious lesions.

116 Ultrasound (US)-guided fine-needle aspiration biopsy of the largest node revealed a

117 Ultrasonography (US)-guided fine-needle aspiration biopsy of the left anterior chest wall

118 anoma may be directed by the results of fine-needle aspiration biopsy of the primary tumor.

119 nts who underwent surgical resection or fine-needle aspiration biopsy of the suspected hyperfunctioni

120 rectomy followed by transvitrector port fine-needle aspiration biopsy of the tumor immediately before

121 Fine needle aspiration biopsy of tumors was done at baseline

122 ties, either computed tomography-guided fine-needle aspiration biopsy or positron emission tomography

123 680) of malignancies would not undergo fine-needle aspiration biopsy or surgery if the SRU guideline

124 Either fine-needle aspiration biopsy or ultrasonography is recommend

125 Secondary outcomes included nodule fine-needle aspiration biopsy rate and physician-reported cli

126 ancer incidence is increasing, and when fine-needle aspiration biopsy results are cytologically indet

127 review of 2,988 consecutive stereotaxic fine-needle aspiration biopsy samples of nonpalpable breast l

128 cer that are beginning to be applied in fine needle aspiration biopsy samples to improve diagnosis.

129 A9 protein in histological sections and fine-needle aspiration biopsy smears of normal kidney, benign

130 lgorithm for prospective MT of in-house fine-needle aspiration biopsy specimens, we conducted a singl

131 n augment the diagnostic specificity of fine-needle aspiration biopsy to better differentiate cytolog

132 Fine needle aspiration biopsy was done and revealed no atypic

133 g needle was utilized in 124 cases, and fine needle aspiration biopsy was performed in 14 cases.

134 Fine-needle aspiration biopsy was used in 10 cases and confir

135 ray-scale thyroid ultrasonography and a fine-needle aspiration biopsy were performed.

136 fact, AFTNs can be safely excluded from fine-needle aspiration biopsy while either (99m)Tc-methoxyiso

137 odal metastases confirmed by results of fine-needle aspiration biopsy who had a clip placed in the ly

138 followed by computed tomography-guided fine-needle aspiration biopsy, is best.

139 tudies were included if 1) mammography, fine-needle aspiration biopsy, or core-needle biopsy was perf

140 erential diagnosis of thyroid tumors by fine needle aspiration biopsy, specifically suspicious or ind

141 aphy (US)-guided core biopsy, US-guided fine-needle aspiration biopsy, surgical excision, and multipl

142 of thyroid abscess material obtained by fine-needle aspiration biopsy.

143 -diagnostic results or spindle cells on fine needle aspiration biopsy.

144 or thyroid nodules is ultrasound-guided fine-needle aspiration biopsy.

145 odules with inconclusive findings after fine-needle aspiration biopsy.

146 ound to be papillary thyroid cancers at fine-needle aspiration biopsy.

147 udies, nodule cytology was evaluated by fine-needle aspiration biopsy.

148 ic follow-up had been recommended after fine-needle aspiration biopsy.

149 rtant issue undermining the benefits of fine-needle aspiration biopsy.

150 ng follow-up is recommended.Keywords: Biopsy/Needle Aspiration, Breast, MammographySupplemental mater

151 Endoscopic ultrasound-fine needle aspiration can be helpful in detecting local recu

152 cteristics plus follow-up cytology from fine-needle aspiration can identify thyroid cancers, it is un

153 In addition, liver fine-needle aspirations captured a heterogeneous liver macrop

154 In 138 (66%), findings at previous fine-needle aspiration cytologic (FNAC) analysis were nondiag

155 Fine-needle aspiration cytologic biopsy and 6 months of follo

156 Diagnosis is based on fine-needle aspiration cytologic examination.

157 of diagnosis, thus avoiding unnecessary fine needle aspiration cytologies.

158 inated by the application of EUS-guided fine needle aspiration cytology (EUS-FNA), and the newest eme

159 ules 1 cm or larger with ultrasound and fine-needle aspiration cytology (FNA).

160 ndoscopic ultrasound (EUS) with/without fine needle aspiration cytology (FNAC) and were followed clin

161 dules frequently require ultrasound and Fine Needle Aspiration Cytology (FNAC) evaluation.

162 Thyroid fine needle aspiration cytology (FNAC) is the standard diagno

163 n the benefit of US elastography-guided fine-needle aspiration cytology (FNAC) over conventional US-g

164 illary ultrasound (AUS) after NAC after fine-needle aspiration cytology can identify abnormal nodes a

165 on.Preoperative axillary ultrasound and fine-needle aspiration cytology has recently been shown to im

166 Fine needle aspiration cytology is central to the evaluation

167 oscopy, endoscopic ultrasonography, and fine-needle aspiration cytology to identify 38 patients who r

168 asis of the imaging findings, US-guided fine-needle aspiration cytology was performed to confirm the

169 hich lesions should be followed without fine-needle aspiration cytology.

170 of 55 years (range, 23-85 years) and a fine-needle aspiration diagnosis of atypia of undetermined si

171 trathyroidal extension, or a definitive fine-needle aspiration diagnosis.

172 d who were led to surgical resection or fine-needle aspiration due to suspicious clinical, laboratory

173 excisional biopsy material rather than fine needle aspiration, due to propensity for focal involveme

174 dobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) are based mostly on retros

175 nchial ultrasonography-guided transbronchial needle aspiration (EBUS-TBNA) biopsies of the hilar and

176 dobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in patients with non-small

177 dobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in the clinical management

178 dobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is an established techniqu

179 dobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is becoming standard of ca

180 dobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is established as an alter

181 dobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is increasingly used for t

182 dobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) or conventional diagnosis

183 EUS-guided fine needle aspiration (EUS-fine needle aspiration), emerging cytologic markers obtained

184 The role of EUS-guided fine-needle aspiration (EUS FNA) in this setting is unclear.

185 garding the accuracy of EUS, EUS-guided fine needle aspiration (EUS-fine needle aspiration), emerging

186 nosed by endoscopic, ultrasound-guided, fine-needle aspiration (EUS-FNA) biopsy and were resected.

187 btained by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) for diagnosis of metastases

188 e usage of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for the diagnosis of solid p

189 guidelines, endoscopic ultrasound with fine-needle aspiration (EUS-FNA) is recommended in pancreatic

190 going endoscopic ultrasonography-guided fine needle aspiration (EUS-FNA) of pancreatic cysts, but the

191 disease, and endoscopic ultrasound with fine needle aspiration (EUS-FNA) remain the preferred methods

192 TBNA, then endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) was allowed as an alternativ

193 Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) was evaluated as a single te

194 Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA), the most sensitive diagnost

195 technique (endoscopic ultrasound-guided fine-needle aspiration [EUS-FNA]) is capable of sampling lymp

196 One-time evaluation with fine-needle aspiration (FNA) and combinations of chemical-shi

197 Clinical specimens obtained through fine-needle aspiration (FNA) and excisional biopsy were teste

198 nsecutive case series and GC testing of fine-needle aspiration (FNA) and formalin-fixed paraffin-embe

199 2016 to April 2022 and residual thyroid fine-needle aspiration (FNA) biopsies obtained from January 2

200 nts younger than 19 years who underwent fine-needle aspiration (FNA) biopsy between January 2004 and

201 Fine needle aspiration (FNA) biopsy of thyroid nodules is a s

202 ate or suspicious cytologic features on fine needle aspiration (FNA) biopsy require thyroidectomy bec

203 milar ex vivo analysis was performed on fine needle aspiration (FNA) biopsy samples from four murine

204 separate cohort of 217 residual thyroid fine-needle aspiration (FNA) biopsy specimens obtained from J

205 priate clinical workup with imaging and fine-needle aspiration (FNA) biopsy to evaluate for cancer.

206 molecular work-up of thyroid nodules on fine needle aspiration (FNA) cytology samples has given clini

207 utility of endoscopic ultrasound (EUS)/fine needle aspiration (FNA) for detection of MRLNs in extrah

208 ted tomography (CT)-guided percutaneous fine-needle aspiration (FNA) has become the procedure of choi

209 endobronchial ultrasound-guided (EBUS) fine-needle aspiration (FNA) has become the standard of care.

210 Fine-needle aspiration (FNA) is increasing in popularity as a

211 ificity of ultrasonographic (US)-guided fine-needle aspiration (FNA) of axillary lymph nodes for preo

212 CT-guided fine-needle aspiration (FNA) of lung lesions is subject to sa

213 Subsequent diagnostics included fine needle aspiration (FNA) of suspicious lesions and mini-l

214 Fine-needle aspiration (FNA) of thyroid nodules has become th

215 Fine-needle aspiration (FNA) or stereotactic core biopsy was

216 We amplified RNAs from 63 fine needle aspiration (FNA) samples from 37 s.c. melanoma me

217 Data from 195 fine-needle aspiration (FNA) samples were used to define mRNA

218 and molecular testing of thyroid nodule fine-needle aspiration (FNA) specimens has been proposed as a

219 ic staging can be achieved at EUS using fine-needle aspiration (FNA) to obtain cytology from suspect

220 not simple cysts should be studied with fine-needle aspiration (FNA).

221 detected and sampled effectively by EUS-fine needle aspiration (FNA).

222 rgoing endoscopic ultrasonography (EUS) fine-needle aspiration (FNA).

223 the combination of imaging and guided, fine-needle aspiration (FNA).

224 ignant lesions in vivo while performing fine needle aspiration (FNA).

225 of thyroid bed lesions; and results of fine-needle aspiration (FNA).

226 Computed tomography-guided fine-needle aspiration for Gram stain and cultures is unneces

227 Cytological study of EUS-guided fine needle aspiration from the mass was suggestive of squamo

228 A expression in metastases by obtaining fine-needle aspirations from 52 tumor lesions in 30 patients

229 Transbronchial needle aspiration guided by endobronchial ultrasound sho

230 ing of on-site cytopathology, transbronchial needle aspiration has a high sensitivity, specificity, a

231 The evaluation of thyroid nodules by fine-needle aspiration has been the standard for almost 30 ye

232 Transbronchial needle aspiration has emerged as a key technique for sam

233 rently, endoscopic ultrasound transbronchial needle aspiration has emerged as an accurate and sensiti

234 he role of endoscopic ultrasound-guided fine-needle aspiration in diagnosing various pancreatic disea

235 as largely replaced fluoroscopic-guided fine-needle aspiration in PTLB.

236 c yield of endoscopic ultrasound-guided fine needle aspiration include performing cyst wall cytology

237 ies and endoscopic ultrasonography with fine-needle aspiration initially declining or accepting immed

238 Needle aspiration/irrigation alone has been described as

239 CT-guided percutaneous needle aspiration is an accurate method for identifying

240 pic characterization of the lesion with fine needle aspiration is critical for treatment decisions an

241 Endoscopic ultrasound-guided fine needle aspiration is generally adequate for tissue acqui

242 Lymph node fine-needle aspiration is positive for malignant cells.

243 (Radiofrequency, Thermal, Chemical), Biopsy/Needle Aspiration, Lung, Electrocardiogram (C) RSNA, 202

244 luation by endoscopic ultrasound-guided fine needle aspiration may further expand the role of endosco

245 nchial ultrasonography-guided transbronchial needle aspiration mediastinal staging (EBUS group) in 62

246 Mediastinal lymph node fine needle aspiration (MLN-FNA) is a common procedure; howev

247 US fusion biopsies upon RP.Keywords: Biopsy/Needle Aspiration, MR-Imaging, Oncology, Pathology, Pros

248 ue sampling with core-needle (n = 6) or fine-needle aspiration (n = 20) biopsy, corticosteroid or con

249 Diagnosis was established with fine-needle aspiration (n = 55), 14-gauge core-needle biopsy

250 dobronchial ultrasound-guided transbronchial needle aspiration-negative, and 1 without available hist

251 ring RFA included nodules with 2 benign fine-needle aspirations, no suspicious ultrasonography featur

252 A cytologically positive transbronchial needle aspiration occurred with the first aspirate in 42

253 2 of 3 on core biopsy, with a positive fine-needle aspiration of a palpable, ipsilateral axillary ly

254 Fine needle aspiration of a right axillary node confirmed met

255 We show that fine needle aspiration of cancer provides a fast and efficien

256 ed minimally invasive ultrasound-guided fine-needle aspiration of the LN to a before-and-after study

257 Fine needle aspiration of the mass suggested a diagnosis of p

258 CT-guided fine-needle aspiration of the splenic lesion was performed an

259 facilitating tissue acquisition through fine needle aspiration of the tumor and surrounding lymph nod

260 EUS can also guide needle aspiration of these lesions to obtain diagnostic

261 y and endoscopic ultrasonography-guided fine-needle aspiration offer high diagnostic ability for panc

262 esults were obtained for samples obtained by needle aspiration or arthroscopic lavage, suggesting a w

263 Fine-needle aspiration or biopsy of all the lesions was perfo

264 r biopsy procedures and the success rate for needle aspiration or catheter drainages for CT fluorosco

265 llected by endoscopic ultrasound-guided fine-needle aspiration or surgery and were preserved as breat

266 atients referred for US with subsequent fine-needle aspiration or with surgical histologic analysis u

267 and accuracy of EBUS and CT-scan versus fine needle aspiration pathology results were determined in t

268 dobronchial ultrasound-guided transbronchial needle aspiration, PET, and brain MRI) by a clinical tum

269 ignancy, the need for ultrasound-guided fine needle aspiration, preoperative staging, lymph node mapp

270 try were performed on all patients, and fine-needle aspiration procedures were performed on suspected

271 The finding of a follicular neoplasm on fine-needle aspiration prompts many surgeons to perform intra

272 and 148 patients (3.7%) had biopsy- or fine-needle aspiration-proven RS.

273 um assisted needle biopsy, image-guided fine needle aspiration, punch biopsy, and open surgical biops

274 scheduled for surgery after a previous fine-needle aspiration report of "atypia of undetermined sign

275 Pancreatic endoscopic ultrasound with fine needle aspiration revealed cytomorphologic features sugg

276 nalysis of endoscopic ultrasound-guided fine-needle aspiration samples has the potential to improve c

277 s, to predict chemotherapy responses in fine-needle aspiration samples in neoadjuvant chemotherapy, a

278 miRNAs in endoscopic ultrasound-guided fine-needle aspiration samples makes them good biomarker cand

279 merging cytologic markers obtained from fine needle aspiration samples, and the role of EUS screening

280 Fine needle aspiration should be considered in adolescents, i

281 with a solitary thyroid nodule in whom fine-needle aspiration showed a follicular neoplasm.

282 nhanced by the ability to obtain guided fine needle aspiration specimens for cytology from any suspic

283 med with oligonecleotide microarrays on fine-needle aspiration specimens.

284 antibodies, positive results on recent fine-needle aspiration, suspected enlarging mass, and abnorma

285 graphy (CT) of the chest with transbronchial needle aspiration (TBNA) in the staging of bronchogenic

286 Transbronchial needle aspiration (TBNA) of intrathoracic lymph nodes ha

287 ivariate analysis, peripheral transbronchial needle aspiration (TBNA), larger lesion size, nonupper l

288 sis as compared with standard transbronchial needle aspiration (TBNA).

289 s controversy regarding the role of EUS fine-needle aspiration, the findings of which may enhance dia

290 Fine-needle aspiration, the presence of extraintestinal gas o

291 Keywords: Biopsy/Needle Aspiration, Thorax, CT, Pneumothorax, Core Needle

292 Keywords: PET/CT, Biopsy/Needle Aspiration, Thorax, Lung, Inflammation, Observer

293 with intravenous contrast and possible fine needle aspiration to detect the presence of sterile or i

294 Here we used ultrasound-guided fine needle aspiration to serially sample the draining lymph

295 firm that ultrasound-directed transbronchial needle aspiration (USTBNA) results in: (1) improved sens

296 Although no difference was found for fine-needle aspiration versus core biopsy of malignant lesion

297 Hepatic fine needle aspiration was performed before treatment and at

298 EUS-guided fine-needle aspiration was performed on sites that were suspi

299 nd incisional biopsies, core needle and fine needle aspiration were 12% (PR, 0.88; 95% CI, 0.81-0.96;

300 Blood and liver fine-needle aspirations were collected, and cellular and mole